Given that CD8+ T cells play a critical role for the elimination of tumor in both models, we speculate that the effect of CD4+ T cell depletion on therapeutic efficacy of vaccines goes through CD8+ T cells as a downstream target. The gene discussed is CD8A; the disease is neoplasm.